il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

More documents

Recommendations

Info

Minotti,G., P.Menna, E.Salvatorelli, G.Cairo, and L.Gianni '2004' "Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and c ardiotoxic ity." P h arm a c o I - Rev. 5 6 :1 8 5 -229' Minow,R.A. and J.A.Gottlieb. 197 5 . "Letter: Adriamycin cardiotoxicity. " Ann. Intern. Med. 82 : 85 5 -85 6. Misao,J., Y.Hayakawa, M.Ohno, S.Kato, T.Fujiwara, and H.Fujiwara. 1996' "Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction." Circulation. 94:1506-1512. Miyashita,T., M.Harigai, M.Hanada, andJ.C.Reed' 1994' "Identification of a p53- dependent negative response element in the bcl-2 gene." Cancer Res' 54:313I- 3 135. Miyashita,T. and J.C.Reed. 1995. "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene." Cell' 80:293-299' Moasser,M.M., R.J.Motzer,K.S.Khoo, P.Lyn, B.A.Murphy, G.J.Bosl, and E'Dmitrovsky' 1995. "all-trans retinoic acid for treating germ cell tumors. ln vitro activity and results of a phase II trial." Cancer.76:680-686. Molavi,B., H.Chen, and D.Li. Preservation of LV function following ischemiareperfusion by the PPAR-gamma ligand rosiglitasone. Circulation 106(Suppl II), 168. 2005. Ref Type: Generic Moreno,P.R. and V.Fus ter. 2004. "New aspects in the pathogenesis of diabetic atherothromb o sis. " J' Am' C o I l. C ar di o l. 4 4 :229 3 -23 00' Moreno-M anzano,Y .,Y.Ishikawa, J.Lucio-C azana, and M.Kitamura. 1999 ' "Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun n-terminal kinase-AP- 1 pathway. " J' B i ol. Ch em. 27 4:2025 | -20258' t56
Morriss-Kay,G.M. and s.J.ward. 1999. "Retinoids and mammalian development'" Int. Rev. CYtol. 188 :7 3 -13 1 . Muggia,F.M. and M.D.Green. 1991. "New anthracycline antitumor antibiotics." Crit. Rev. Onco l. Hemat ol' | | :43 -64. Mukai,F.H. and B.D.Goldstein. 1976. "Mutagenicity of malonaldehyde, a decomposition product of peroxidized poiyunsaturated fatty acids." Science. 191:868-869. Myers,c.E., 'w.P.McGuire, R.H.Liss, I.Ifrim, K.Grotzinger, and R.c.Young. 1977 ' "Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response." Science. 197 :165-167' Nadin,L. and M.Munay.1999. "Participation of CYP2C8 in retinoic acid 4- hydroxylation in human hepatic microsome s." B iochem. Pltarmacol. 5 8 : 1 20 1 - 1208. Nagy,L., H.Y.Kao, D.Chakravarti, R.J.Lin, C.A.Hassig, D.E.Ayer, S.L.Schreiber, and R.M.Evans .lgg7. "Nuclear receptor repression mediated by a complex containing SMRT,msin3A,andhistonedeacetylase'"Cell'89:373-380' Nagy,L., V.A.Thomazy, R.A.Heyffian, and P.J.Davies. 1998. "Retinoid-induced apoptosis in normal and neoplastic tissues." Cell Death.Differ' 5:Il-1'9. Nakamura,T., S.Mizuno, K.Matsumoto, Y.Sawa, H.Matsuda, and T.Nakamura' 2000' "Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF." J.Clin.Invesr. 106:15 1 1-1519' Napoli,J.L. 1996. "Biochemical pathways of retinoid transport, metabolism, and signal transductio n." CIin' Immun o I. Immunop atho I' 8 0 : S 5 2- S 62' Napoli,J.L. 1999. "Retinoic acid: its biosynthesis and metabolism." Prog.Nucleic Acid Res.MoLBiol. 63 :139 -188. t57
Page 1 and 2:
il\VOLVEMENT OF RETII\OIC ACID II{
Page 3 and 4:
Title: AKNOWLEDGMENTS DEDICATION LI
Page 5 and 6:
IV.b.3. The uptake to peripheral ti
Page 7 and 8:
II.a. Total RAR and total RXR recep
Page 9 and 10:
ACKNO\ryLEDGMENTS I must say that m
Page 11 and 12:
DEDICATION To my toughest critic, m
Page 13 and 14:
Figure: LIST OF FIGURES Page: 1. Ch
Page 15 and 16:
30. A and B The expression of anti-
Page 17 and 18:
treated (ADR), trolox treated (TROL
Page 19 and 20:
INTRODUCTION Adriamycin, an anthrac
Page 21 and 22:
apoptosis, which will ultimately pr
Page 23 and 24:
LITERATURE REVIE\il I. Adriamycin i
Page 25 and 26:
Binding and alkylation of DNA Inter
Page 27 and 28:
myocardial inflammation which was s
Page 29 and 30:
1990; Kusuoka et al. l99l; Olson et
Page 31 and 32:
levels of antioxidant enzymes (Odom
Page 33 and 34:
causing the increased leakage of el
Page 35 and 36:
mechanisms which are involved in th
Page 37 and 38:
to protect against adriamycin-induc
Page 39 and 40:
The usage of Probucol.' Most promis
Page 41 and 42:
II. Oxidative stress II.a. Introduc
Page 43 and 44:
of a large array of cellular abnorm
Page 45 and 46:
menstruation (Kokawa et al. 1996),
Page 47 and 48:
DNA(Cohen 1997; Saikumar et al. 199
Page 49 and 50:
pathogenesis of heart failure. A nu
Page 51 and 52:
elonging to spontaneous hlpertensiv
Page 53 and 54:
AlþTrsns Retlnolc Acld fAfRAl g€
Page 55 and 56:
dehydrogenase (SDR), alcohol dehydr
Page 57 and 58:
(Bavik et a|. 1991). Soon after its
Page 59 and 60:
et al. 1994; Napoli 1996). The func
Page 61:
is achieved through its binding to
Page 64 and 65:
Retinoic acid signaling pathwaybegi
Page 66 and 67:
(Bavik et al. 1997). One of the mos
Page 68 and 69:
cells (Gaetano et ai. ZOot¡. The s
Page 70 and 71:
neuroblastoma, genn cell tumors and
Page 72 and 73:
presence of two distinctive pathway
Page 74 and 75:
cytochrome C release from mitochond
Page 76 and 77:
peroxidation (Sultana et a|.2004).
Page 78 and 79:
adipose tissue and to a lesser exte
Page 80 and 81:
such as; increased generation of re
Page 82 and 83:
physiological and pathological proc
Page 84 and 85:
Protective effects of PPAR y agonis
Page 86 and 87:
IIYPOTHESIS This study tests the hy
Page 88 and 89:
I.c.Collection of Tissues Hearts we
Page 90 and 91:
thoracotomy was performed and heart
Page 92 and 93:
Il.c.Western Blot Analvsis Western
Page 94 and 95:
green were counted as dead cells. T
Page 96 and 97:
RESULTS I.In Vivo Studies I.a.Gener
Page 101:
Lc. Retinoic acid receptors Three w
Page 108:
The RAR o and PPAR-õ receptors RNA
Page 113 and 114:
significantly decreased when compar
Page 116:
IL b.7. RAR alPha recePtor levels T
Page 120:
ILb. 3. RAR sammø recEtor levels F
Page 124: ILb. 5. RXR baa recEúor levels The
Page 129: visible staining were accounted as
Page 137 and 138: DISSCUSION I. Adriamvcin CardiomvoP
Page 139 and 140: Treatment with adriamycin has been
Page 141 and 142: High RA 1 Adriamycin I oxidative st
Page 143 and 144: study as well as in others (Kumar e
Page 145 and 146: It is reported that PPAR y receptor
Page 147 and 148: expression. These effects of trolox
Page 149 and 150: REFERENCES Abdul Hamied,T.A., D.Par
Page 151 and 152: Bashor,M.M., D.O.Toft, and F.Chytll
Page 153 and 154: distribution of PPAR-alpha, -beta,
Page 155 and 156: colbert,M.C., D.G.Hall, T.R.Kimball
Page 157 and 158: Diep,Q.N., M'El Mabrouk, J.S.Cohn,
Page 159 and 160: Evans,R.M. 1988. "The steroid and t
Page 161 and 162: Ghione M. Development of Adriamycin
Page 163 and 164: Herman,E., R.Young, and S.Krop . Ig
Page 165 and 166: morphogenetic protein-2 inhibits se
Page 167 and 168: Khandoudi,N., P.Delerive, I.Berrebi
Page 169 and 170: Kusuoka,H., S.Futaki, Y.Koretsune,
Page 171 and 172: and myosin heavy chain gene express
Page 173: Mehta,J.L., B.Hu, J.Chen, and D.Li.
Page 177 and 178: Notario,B., M.Zamora, O.Vinas, and
Page 179 and 180: petkovich,M., N.J.Brand, A.Krust, a
Page 181 and 182: Ruberte,E., P.Dolle, P.Chambon, and
Page 183 and 184: Sharov,V.G., H.N.Sabbah, H.Shimoyam
Page 185 and 186: spiegelman,B.M. and J.s.Flier .1996
Page 187 and 188: Teebor,G.w., R.J.Boorstein, and J.c
Page 189 and 190: vanVeen,T.A.,H.V.vanRijen,R.F.V/ieg
Page 191 and 192: wi1liams,J.B. and J.L.Napoli. 1985.
Page 193 and 194: peroxisome proliferator-activated r
show all

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?